GlassScriptPhysician profile
William L Johnson
NPI 1073668604
$1,236.41
in general payments reported to CMS, 2019-2025
13 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $351 · 2020: $283 · 2021: $298 · 2024: $304.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Long Term Medical Supply Or Device Loan: $245 · Food and Beverage: $58.59.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Long Term Medical Supply Or Device Loan | $245.39 |
| Food and Beverage | $58.59 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pacira Therapeutics, INC. | $623.30 | 2019-2021 | |
| Integra Lifesciences Corporation | $261.74 | 2024 | Acell, Integra, Primatrix |
| Amgen INC. | $91.70 | 2020-2021 | |
| Depuy Synthes Sales INC. | $53.84 | 2019-2020 | |
| Kerecis Limited | $42.24 | 2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide |
| Avanos Medical | $28.77 | 2021 | |
| Zyla Life Sciences, INC. | $26.31 | 2019 | |
| Sanofi-Aventis U.S. LLC | $23.90 | 2019 | |
| Medartis INC. | $22.19 | 2019 | |
| Acell, INC. | $22.09 | 2019 | |
| Orthogenrx INC. | $15.88 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $12.44 | 2021 | |
| Cumberland Pharmaceuticals, INC. | $12.01 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw William Johnson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.